Adam B. Goldin

Adam B. Goldin

Auto-generated profile, based on publicly available information

Adam B. Goldin

Division of Pediatric General and Thoracic Surgery, Seattle Children's Hospital, Seattle, Washington

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2011 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
AGAdam B. Goldin
Adam B. Goldin
PKParitosh Khanna
Paritosh Khanna
MTMahesh Thapa
Mahesh Thapa
JMJennifer A. McBroom
Jennifer A. McBroom
MGMichelle M. Garrison
Michelle M. Garrison
MPMarguerite T. Parisi
Marguerite T. Parisi

1 February 2019 in The Journal of Pediatrics
Verified
Journal Article
Closed access
LBLoren Berman
Loren Berman
MRMehul V. Raval
Mehul V. Raval
MOMadelene Ottosen
Madelene Ottosen
AMAnne Kim Mackow
Anne Kim Mackow
MCMaria Cho
Maria Cho
AGAdam B. Goldin
Adam B. Goldin

1 July 2016 in The Journal of Pediatrics
Verified
Journal Article
Closed access
AGAdam B. Goldin
Adam B. Goldin
KHKurt F. Heiss
Kurt F. Heiss
MHMatt Hall
Matt Hall
DRDavid H. Rothstein
David H. Rothstein
PMPeter C. Minneci
Peter C. Minneci
MAMarjorie J. Arca
Marjorie J. Arca

1 September 2013 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
JMJarod P. McAteer
Jarod P. McAteer
AGAdam B. Goldin
Adam B. Goldin
PHPatrick J. Healey
Patrick J. Healey
KGKenneth W. Gow
Kenneth W. Gow

1 December 2006 in Pediatrics
Verified
Journal Article
Closed access
PDF file
AGAdam B. Goldin
Adam B. Goldin
RSRobert Sawin
Robert Sawin
KSKristy D. Seidel
Kristy D. Seidel
DFDavid R. Flum
David R. Flum
OBJECTIVE. Gastroesophageal reflux disease is extremely common in the pediatric population, and antireflux procedures are performed with increasing frequency. The objective of this study was to determine whether pediatric antireflux procedures are associated with a decreased rate of reflux-related hospitalizations.METHODS. A study was conducted of pediatric patients who were undergoing antireflux procedures using data that were derived from the Washington State Comprehensive Hospital Abstract Reporting System and Vital Records. Patients were identified by a search of all records (1987–2001) for procedure codes that pertained to antireflux procedures in patients who were younger than 19 years. The number of hospitalizations for and rates of reflux-related events per patient-year before and after an antireflux procedure was calculated, and factors that were associated with higher antireflux procedure rates were examined.RESULTS. A total of 1142 patients underwent antireflux procedures. The rate of reflux-related events declined sharply with age both before and after an antireflux procedure. The cohort was divided into 3 groups on the basis of age at first antireflux procedure (<1 year, 1–3 years, or 4–19 years), and the calculations of incidence rate ratios before to after an antireflux procedure were done within the same age strata. Results suggest an overall benefit of antireflux procedures in young children. For antireflux procedures that were performed in children who were older than 4 years, the benefit is less clear. Developmental delay was significantly associated with higher rates of reflux-related events among patients who underwent an antireflux procedure after age 4.CONCLUSIONS. The rate of reflux-related events was lower after an antireflux operation for children who underwent an antireflux procedure before age 4. Older children, however, were hospitalized at equal rates before and after an antireflux procedure, and older children with developmental delay were hospitalized at greater rates after an antireflux procedure. These findings highlight the need to clarify the subjective and objective indications for antireflux procedures in infants and children.

1 May 2007 in Pediatrics
Verified
Journal Article
Closed access
PDF file
AGAdam B. Goldin
Adam B. Goldin
RSRobert S. Sawin
Robert S. Sawin
MGMichelle M. Garrison
Michelle M. Garrison
DZDanielle M. Zerr
Danielle M. Zerr
DCDimitri A. Christakis
Dimitri A. Christakis
OBJECTIVE. We conducted a retrospective cohort study to compare the use of triple therapy versus monotherapy for children and adolescents with perforated appendicitis and to determine whether there has been a transition to monotherapy within the freestanding children's hospitals that contribute to the Pediatric Health Information System database.METHODS. We used the Pediatric Health Information System database, which includes billing and discharge data for 32 children's hospitals in the United States, to examine the trend in antibiotic usage and whether the postappendectomy antibiotic regimen was associated with differences in complication-related readmissions, length of stay, or charges in a population of children and adolescents with ruptured appendicitis and discharge dates between March 1, 1999, and September 30, 2004. Pairwise regression analyses were performed to compare the most common monotherapy regimens with the triple therapy.RESULTS. A total of 8545 patients met the inclusion criteria, of whom 58%, over the entire study period, received the aminoglycoside-based triple antibiotic therapy on postoperative day 1. There was, however, a notable transition over this 6-year period, from 69% to 52% of surgeons using aminoglycoside-based combination therapy. There were no significant differences in the odds of readmission at 30 days except for the group receiving ceftriaxone, which was associated with significantly decreased odds. The subgroup receiving piperacillin/tazobactam monotherapy demonstrated significantly decreased length of stay (−0.90 days) and total hospital charges, and the group receiving cefoxitin demonstrated significantly decreased length of stay (−1.89 days), as well as decreased pharmacy and total hospital charges.CONCLUSIONS. Single-agent antibiotic therapy in the treatment of perforated appendicitis is being used with increasing frequency, is at least equal in efficacy to the traditional aminoglycoside-based combination therapy, and may offer improvements in terms of length of stay, pharmacy charges, and hospital charges.